Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001628280-22-030745 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-21 | AUPH | Donley Matthew Maxwell | Ex VP, Internal Ops | P - Purchase | $4.66 | +10.0K | 27.9K | +56% | +$46.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | P | A | 10,000 | $4.66 | 27,927 | D | — | — | (F1) Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan. |